LINCOLN PHARMACEUTICALS LTD. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11 Apr 2022
Pursuant to provision of Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby submit the confirmation certificate as received from M/s. Link Intime India Private Limited, Registrar & Share Transfer Agent (RTA) for the Quarter Ended March 31, 2022.
Source:
BSE India